<DOC>
	<DOC>NCT02021500</DOC>
	<brief_summary>A study to collect survival data on patients previously enrolled in Abraxane pancreatic cancer study CA046.</brief_summary>
	<brief_title>A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.</brief_title>
	<detailed_description>A study to collect survival status of CA046 subjects who were know to be alive at the last report of vital status for CA046 - approximate timeframe - end of March, 2013. Once consent is given, on a quarterly basis, information on status will be collected to include: - Vital Status - Date of disease progression - Subsequent anticancer therapy for pancreatic adenocarcinoma</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Must have been enrolled in the CA046 study Must have been living at the time of the last survival followup (approximate timeframe end of March, 2013) Must understand and be able to give informed consent (if a subject is deceased, proper legal consent (ie, next of kin, legal representative) will be obtained prior to collection of data) Consent refused for any reason</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>